ID
33505
Description
Study ID: 104297 Clinical Study ID: 104297 Study Title: An open study for a 2-year period to confirm the safety and immunogenicity of the candidate malaria vaccine RTS,S/AS02A in Mozambican children aged 1 to 4 years at the time of first vaccine dose. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00323622 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: SB257049 Trade Name: SB257049 Study Indication: Malaria
Keywords
Versions (3)
- 12/11/18 12/11/18 -
- 12/11/18 12/11/18 -
- 6/6/19 6/6/19 -
Copyright Holder
GSK group of companies
Uploaded on
December 11, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Immuogenicity of malaria vaccine candidate in Mozambican children (1 to 4 y.o) - 104297 (Malaria039)
Reason for Non Participation - Tracking Form
- StudyEvent: ODM
Description
Reason for non participation
Description
Subject Number
Data type
integer
Description
Subject could not be reached due to
Data type
text
Description
Subject could be contacted
Data type
text
Description
if applies
Data type
text
Description
if applies
Data type
text
Description
Day of contact
Data type
date
Description
In case of death, date of contact not requested
Description
Investigator's Signature
Similar models
Reason for Non Participation - Tracking Form
- StudyEvent: ODM